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Multiple subtypes of HIV-1 have been identified; however, there is little data on the relative transmissibility of viruses
belonging to different subtypes. A matched case-control study addressed whether viruses with different long terminal repeat
(LTR) subtypes were transmitted equally from mother to infant. The LTR subtype was determined for 45 matched cases and
controls who participated in a clinical trial in Tanzania. HIV-1 subtypes A, C, and D and intersubtype recombinant sequences
were identified. Exact matched logistic regression analysis showed that viruses containing subtype A or intersubtype
recombinant LTRs were 3.2 and 4.8 times more likely to be transmitted from mother to infant than viruses with subtype D
LTRs. Viruses containing subtype C LTRs were 6.1 times more likely to be transmitted than those with subtype D LTRs. These
differences in transmission were independent of maternal CD4 at enrollment. Thus, it appears that HIV-1 subtype may be
associated with differing rates of perinatal transmission in Tanzania. © 2001 Academic PressIntroduction. Analyses of human immunodeficiency vi-
rus type 1 (HIV-1) structural gene sequences from differ-
ent geographic regions have revealed the existence of
multiple subtypes that are unevenly distributed around
the world. Infection of the same individual with more than
one HIV-1 subtype may result in the generation of inter-
subtype recombinant viruses. Approximately 20% of hu-
man immunodeficiency viruses have been described as
recombinant viruses; however, this figure is likely an
underestimate of the true extent of recombination, as
many mosaic viruses may be overlooked when only a
limited portion of the viral genome is analyzed. There is
mounting evidence that HIV-1 subtypes may differ in
biological phenotypes [reviewed in (7)]. For instance,
CD4 counts are lower and plasma viral RNA levels are
higher in individuals infected with HIV-1 subtype C (19);
subtype C viruses utilize the CCR5 chemokine corecep-
tor almost exclusively for cell entry (3, 24); and AIDS-free
survival time appears to be shorter for individuals in-
fected with non-A-subtype viruses (13). Additionally, tran-
scriptional activation of long terminal repeats (LTRs) in
response to cellular proteins and inflammatory cytokines
may differ among subtypes (12, 15, 16, 18).
Previous studies in Tanzania have shown that most
HIV-1 infections were due to subtypes A and D; more1 To whom requests for reprints and correspondence should be
ddressed. E-mail: messex@hsph.harvard.edu.
261recently, our laboratory has documented infections due
to HIV-1 subtype C and intersubtype recombinant viruses
(21). In our studies of Tanzanian infants, we found that
recombination occurred in both structural genes (gag
and env) (22, 23) and nonstructural regions (the long
terminal repeat) (1). We have also shown that the HIV-1
subtype of the LTR found within infants accurately re-
flects the LTR subtype within the mother (1). Because of
the underlying biological significance of LTR activation
and previously observed subtype-specific difference
among LTRs, we have chosen to analyze the LTR sub-
type separately from structural regions of the HIV-1 ge-
nome that may be under different selection pressures.
Here, we determine the extent of intersubtype recombi-
nation within the long terminal repeat and examine the
potential association of LTR subtype with perinatal trans-
mission in an African setting.
Methods. Samples from infants and mothers were
obtained from a randomized double-blind trial to evalu-
ate the potential of vitamin supplements to reduce HIV-1
perinatal transmission in Dar es Salaam, Tanzania (9).
Assessment of HIV status as well as the selection of
controls and cases has been described elsewhere (23).
Briefly, 51 nontransmitter controls were randomly se-
lected and matched with 51 transmitter cases using two
variables: age of the infant at sampling and the calendar
year of enrollment. Baseline demographic, clinical, and
laboratory data were obtained for each pregnant woman
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262 RAPID COMMUNICATIONat recruitment. The mother’s baseline disease was stage
1 (88%) or stage 2 (12%) according to the World Health
Organization HIV disease stage classification.
Peripheral blood mononuclear cells (PBMC) were sep-
arated by Ficoll density gradient centrifugation. The 59
ong terminal repeat (725 bp) or 39 LTR (for 2 controls and
case) was amplified from PBMC crude cell lysates
sing a heminested polymerase chain reaction (PCR).
CR amplicons were purified and cloned for sequencing
sing an ABI373 automated sequencer. The LTR could
ot be amplified from 3 cases and 4 controls (including 1
air for which neither the case nor the control could be
mplified), leaving 45 matched pairs for further analysis.
s a further measure of quality control, laboratory per-
onnel involved in HIV-1 subtype classification were
linded to sample identification and transmission status.
Consensus sequences were aligned in Clustal W with
atabase reference LTRs corresponding to HIV-1 subtypes
through J. All LTR sequences were analyzed using the
ecombinant Identification Program and break point anal-
sis as previously described (1). Nucleotide sequences
ave been submitted to GenBank under Accession Nos.
F096635-AF096636, AF096638-AF096639, AF096641-
F096642, AF096644, AF096646, AF096648, AF096650-
F096651, AF096653-AF096654, AF096657, AF239623,
F239636, AF239639-AF239641, AF239643, AF239645-
F239647, AF239649, AF239655, and AF254673-AF254737.
Univariate analysis was performed for the 45 matched
airs included in this study. The following risk factors for
erinatal transmission were evaluated for transmitting
nd nontransmitting mothers: HIV-1 subtype, maternal
ge, gestational age at birth, duration of membrane rup-
ure, infant birth weight, and maternal CD4 count at study
nrollment. The Wilcoxon rank sum test was used to test
or differences among continuous variables and for dif-
erences between cases and controls within a subtype.
he Kruskal–Wallis test was used to test for differences
n CD4 count among HIV-1 subtypes and for differences
mong subtypes by case status. Exact matched logistic
egression analysis was performed to assess differ-
nces in transmission among different HIV-1 subtypes.
uring the study’s design, subtype D was chosen as the
eference subtype for our matched logistic regression
nalyses as it has been the major HIV-1 subtype in
anzania until recently (21) and likely represents those
nfected with HIV for the longest period of time. P values
less than or equal to 0.05 were considered statistically
significant.
Results. We have shown previously that recombination
occurs within the LTR itself in many viruses with evi-
dence of recombination within either gag or env (1). In
the current study, we have compared the HIV-1 LTR
subtype from 45 matched cases and controls. In agree-
ment with previous studies (1, 2), HIV-1 subtypes A, C,
and D and intersubtype recombinant LTRs were respon-sible for all infections. Subtype A LTRs were identified
within 20 individuals (10 cases and 10 controls), subtype
C in 28 (19 cases and 9 controls), and subtype D in 20 (4
cases and 16 controls). Intersubtype recombinant LTRs
were identified in 22 individuals (12 cases and 10 con-
trols). The number of samples with break points within
the regions sequenced demonstrate that recombination
within the LTR is more frequently observed than recom-
bination within the gag or the env regions. Within the 45
controls, 10 samples had recombinant LTRs (22%), 1
sample had a recombinant gag (2%), and 4 samples had
a recombinant env (9%). In the 45 cases, 12 samples had
recombinant LTRs (27%), 2 samples had a recombinant
gag (4%), and 2 samples had a recombinant env (4%)
(Table 3). In addition, several patterns of recombination
within the LTR were observed. Interestingly, the subtype
C modulatory region—containing three NF-kB enhanc-
ers—was retained in 8 of 12 (67%) cases, but only 3 of 10
(30%) controls. Our results also suggest that the number
of additional recombinant viruses identified by including
LTR subtype data with the previous gag plus env subtype
data is small (data not shown).
We assessed whether cases and controls differed in
potential risk factors associated with perinatal transmis-
sion. Univariate analysis of matched pairs showed no
significant differences in maternal age, gestational age,
duration of membrane rupture, or birth weight between
transmitting mothers and nontransmitting mothers (Table
1). A comparison of CD4 cell counts at enrollment
showed that transmitting mothers had lower CD4 counts
(mean, 342; SD, 135) compared to nontransmitting moth-
ers (mean, 402; SD, 154; P 5 0.03). However, there was
no difference in CD4 counts among HIV-1 subtypes (P 5
0.80) or among HIV-1 subtypes by case status (P 5 0.88
for controls and P 5 0.96 for cases) according to LTR
subtype data.
The distribution of HIV-1 subtypes according to the
LTR subtype is shown in Table 2. Because this was a
case-control study, the proportion of each subtype does
not reflect the subtype-specific prevalence in the overall
population, nor the rate of transmission of each subtype.
Interestingly, there were 16 controls with subtype D LTRs
but only 4 cases. There were also twice as many cases
with subtype C LTRs as controls (19 cases compared to
9 controls). Exact matched logistic regression analysis
was performed to assess the transmissibility associated
with different HIV-1 subtypes. Using the LTR subtype
classification, the odds of transmission for viruses with
subtype A LTRs were 3.2 times greater than those for
viruses with subtype D LTRs, although this difference did
not reach statistical significance (CI 0.7–21.5, P 5 0.19).
The odds of transmission for viruses with intersubtype
recombinant LTRs were greater than those for viruses
with subtype D LTRs (OR 5 4.8, CI 1.0–34.0, P 5 0.05).








263RAPID COMMUNICATIONLTRs were 6.1 times greater than those for viruses with
subtype D LTRs (CI 1.5–36.4, P 5 0.006).
Discussion. In the present study, we have identified 22
of 90 (29%) individuals with recombinant viruses utilizing
LTR subtype data only. A recent study conducted in
Kenya found no association between the rate of perinatal
transmission and HIV-1 subtype (17). They identified only
5 of 130 (4%) samples as recombinants, although others
have suggested that the prevalence of recombinant vi-
ruses in Kenya may be in excess of 20% (14). In contrast,
we classified nearly 30% of our population as “recombi-
nant” based upon the LTR subtype alone; only a slightly
higher percentage of recombinant viruses were identi-
fied when gag plus env subtyping was determined (23).
Differences in the relative proportion of HIV-1 subtypes in
the study population, the genomic region sequenced,
and the sensitivity of the technique used to assess sub-
type could possibly explain the failure of the Kenyan
study to find any association between perinatal trans-
mission and HIV-1 subtype. Due to the high proportion of
intersubtype recombinant LTRs identified, we propose
that the inclusion of a nonstructural region of the HIV-1
genome such as the long terminal repeat may be partic-
ularly useful for future analyses of recombinants. It is
important to note that, although we noted a higher pro-
portion of intersubtype recombination with the LTR com-
pared to env and gag, discordance between the env and
TABLE 2
Exact Matched Logistic Regression Analysis of Perinatal Transmission
Was Performed Using the HIV-1 LTR Subtype Classification
HIV-1 locus Subtype Controls Cases Odds ratio (95% CI)
LTR only A 10 10 3.2 (0.7–21.5)
C 9 19 6.1 (1.5–36.4)*
REC 10 12 4.8 (1.0–34.0)*
D 16 4 Reference
Note. CI, confidence interval; REC, recombinant. A single asterisk
indicates P values less than or equal to 0.05.
T




aternal age (years) 45
estational age (weeks) 43
uration of rupture of membranes (hours) 43
irth weight (grams) 44
D4 count at enrollment 44
Note. N, sample size; SD, standard deviation; P, P value for matchegag subtypes accounted for nearly all intersubtype re-
combinants in our previous analysis (23). Thus, analyses
of LTR, gag, and env data collectively demonstrated that
29% of controls and 40% of cases were recombinant
viruses. Therefore, the long terminal repeat may aid in
the identification of potential recombinant viruses, while
simultaneously providing important sequence data on
viral regions with subtype-specific, functionally relevant
properties.
We have shown that viruses with subtype C or inter-
subtype recombinant LTRs are more likely to be trans-
mitted from mother to infant than are viruses with sub-
type D LTRs. When other variables potentially associated
with perinatal transmission were controlled for in the
multivariate analysis, odds ratios were usually higher
than those reported in Table 2 and the subtype C odds
ratio was always highly significant. Separate analysis of
combined LTR/gag/env data demonstrates an even
higher odds ratio of transmission (Blackard, Renjifo, and
Essex, unpublished data); thus, additional determinants
of perinatal transmission may be associated with struc-
tural regions of the genome (22).
Previous studies of retroviruses have demonstrated
that interactions of long terminal repeats with transcrip-
tional regulators may determine viral host range, tissue
tropism, replication kinetics, and disease pathogenesis
TABLE 3
Intersubtype Recombination within Regions with Detectable Break
Points within the Region Sequenced: LTR (725 bp), gag (;390 bases),
r env (670 bases)
Recombinants
Total recombinants
(LTR 1 gag 1 env)aLTR Gag Env
Cases 12 (27%) 1 (2%) 4 (9%) 18 (40%)
Controls 10 (22%) 2 (4%) 2 (4%) 3 (29%)
Note. Some samples have crossovers within more than one region.
a Total recombinants include samples with detectable crossovers in
ne or more regions as well as samples with discordant subtypes
etween regions.
smission Was Performed for Matched Cases and Controls
Cases
n (SD) N Mean (SD) P
3 (4.5) 45 25.1 (4.3) 0.85
8 (2.5) 44 38.3 (3.0) 0.40
7 (7.3) 40 3.8 (5.8) 0.94
9 (464.9) 41 3068.3 (447.6) 0.65



































264 RAPID COMMUNICATION(8). Additionally, several studies have demonstrated that
subtle differences in LTR activity may have significant
impact on viral replication (10, 12, 18, 26).
In the current study, we have shown that the subtype
C modulatory region is overrepresented in recombinant
viruses isolated from HIV-positive infants. We (15, 16) and
thers (12, 18) have previously shown that the subtype C
odulatory region is particularly sensitive to NF-kB/rel
proteins and TNF-a. Others have shown that NF-kB stim-
ulation of the long terminal repeat contributes signifi-
cantly to viral replication (4, 5). We hypothesize that LTR
activation through enhancer elements may increase viral
load in compartments critical to perinatal transmission,
such as genital fluids and/or breast milk. Increased viral
load for subtype C has been documented (19) and may
partially explain the increased odds of transmission for
subtype C viruses found in our study, although other
genomic regions of HIV are almost certainly involved as
well. It is clear that further studies are necessary to
elucidate the role of LTR variation with respect to viral
load, transmission, and disease progression.
One limitation of our study design is that viral load
data are not currently available from our study popula-
tion. As our data are derived from a larger study address-
ing the potential effects of vitamin supplements on HIV
transmission, HIV-1 viral load measurements were not
initially included in the study design. We agree that viral
load data for these individuals would be useful; however,
the aim of our study was to address the potential asso-
ciation between HIV-1 subtype and perinatal transmis-
sion. Although viral load may be along the causal path-
way (subtype3 viral load3 transmission) from subtype
to transmission, the association between viral load and
perinatal transmission has been thoroughly examined
elsewhere.
Despite recent improvements in viral load assays,
HIV-1 subtype variation is still a major impediment to
accurate viral load quantification (20, 25). It seems likely
that the high proportion of intersubtype recombinant vi-
ruses, as well as the presence of three HIV-1 subtypes in
Tanzania, would make reproducible, accurate estimates
of viral load difficult without extensive prior standardiza-
tion of assays. Thus, because of a lack of a “gold stan-
dard” viral load assay, we chose maternal CD4 count as
an indicator of transmission. Maternal CD4 count has
been used previously as an indicator of disease progres-
sion and transmission, as its measurement is indepen-
dent of the viral subtype and, therefore, unlikely to con-
found our analysis (6). More recently, standardized viral
load assays have been conducted in Tanzania. Prelimi-
nary analysis of a limited number of controls (n 5 11) and
ases (n 5 6) from this study suggests no difference in
ean viral load (20,100 copies/mL versus 19,900 copies/
L) between these groups (P 5 0.82 by Wilcoxon test).
lthough the relatively small sample size of our study
ay appear to be a limitation, the statistical analysis weerformed—exact matched logistic regression—was
tilized specifically for its ability to take into account
imited sample sizes (11). Although the overall transmis-
ion rate in the population is currently unavailable, we
re currently completing an estimate of the HIV-1 sub-
ypes in the mother population of our larger cohort. This
ill complement existing data on the HIV-1 subtypes
revalent in the infant population. This information will
rovide invaluable estimates of the overall perinatal
ransmission rate as well as subtype-specific estimates
f transmission in Tanzania.
We have shown that HIV-1 LTR subtype is associated
ith perinatal transmission. This association may be the
esult of higher viral load for some HIV-1 subtypes or may
e the result of other, undefined viral characteristics.
owever, it seems likely that HIV-1 subtype, viral load,
nd transmission are intimately correlated.
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